Ftse Mib
33.822,44
0,34%
DAX
18.340,05
0,98%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.681,01
-0,21%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Biostar Pharmaceuticals Inc (CE) (BSPM) Biostar Pharmaceuticals Inc (CE) (BSPM) Notizie

BSPM

Biostar Pharmaceuticals (CE) (BSPM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:BSPM
DataOraFonteTitoloSimboloCompagnia
08/01/201916:16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
24/08/201815:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/08/201814:51GlobeNewswire Inc.Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from NasdaqUSOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/07/201823:26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
16/05/201822:12Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/04/201822:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
01/02/201822:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
20/11/201722:11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/04/201722:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
13/04/201722:05Edgar (US Regulatory)Annual Report (10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
20/01/201712:02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
13/01/201722:20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
30/12/201622:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/10/201622:26Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
12/10/201622:46Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
18/07/201414:44Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
11/01/201322:34Edgar (US Regulatory)Current report filing (8-K)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/11/201213:33Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/11/201214:03Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/09/201222:31Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/04/201223:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
27/03/201213:34Edgar (US Regulatory)Annual Report (10-K)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/12/201122:55Edgar (US Regulatory)Amended Current report filing (8-K/A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
01/06/201120:39Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/05/201116:08Edgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
05/04/201115:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
28/03/201112:50GlobeNewswire Inc.Biostar Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.comUSOTC:BSPMBiostar Pharmaceuticals Inc (CE)
29/12/201015:58Edgar (US Regulatory)Statement of Ownership (SC 13G)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/04/201014:45Edgar (US Regulatory)Securities Registration (section 12(b)) (8-A12B)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
18/02/201007:30GlobeNewswire Inc.EquityNet Research Initiates Independent Research Coverage on Biostar Pharmaceuticals, Inc.USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:BSPM

La tua Cronologia

BIT
UCG
Unicredit
BIT
SPM
Saipem
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
FCTAAW
Fincantieri
BIT
SRG
Snam
BIT
FCT
Fincantieri
BIT
TIT
Telecom Italia
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network